Views & Analysis | Perspectives on pharma industry issues

R&D

Empty waiting room chairs for clinical trial enrolment

When metrics measure more than they improve

The question to ask is not, "Are we measuring site performance?" but, "Are the metrics we collect providing actionable insights early enough?"

Market Access

What India can learn from Kinvard Bio

India needs its own version of pull, designed for an Indian payer mix, an Indian procurement structure, and an Indian distributor network.

Sales & Marketing

Recruitment concept graphic on beige background

Changing Faces: Agency, consultancy, and investor hires, Jun...

Agencies, consultancies, investment groups, and wider services firms saw significant talent movement across June and July.

Market Access

The new commercialisation playbook: What BIO 2026 taught eme...

BIO International focused on how emerging biotech companies should approach their first product launch outside the United States, typically in Europe.

Patients

Physical performance × nutrition — a multiplicative relation...

Physical performance and nutrition are not just complementary, but biologically multiplicative.

Digital

Bridging the digital divide: Empowering healthcare through i...

Transitioning from my role as a pharmacist to becoming a project manager in healthcare technology was not just a professional milestone, but a deeply transformative journey.

Market Access

Why the NHS needs to maximise the impact of biosimilars

Ensuring the long-term sustainability of the NHS increasingly appears to be an unfathomable prospect.

Sales & Marketing

Sponsored

5 strategies to retain top talent

The pharma sales industry is in the midst of rapid transformation, fuelled by digital disruption and dynamic market forces.

Sales & Marketing

Changing Faces: Agency, consultancy, and investor hires, Jun...

Agencies, consultancies, investment groups, and wider services firms saw significant talent movement across June and July.

Sales & Marketing

Sponsored

Personalisation is the biggest lie brands keep telling

Pharma brands need to move beyond surface-level personalisation and focus on measurable impact.

Digital

Sponsored

Technology solutions for smarter clinical trials: Inventus

In an exclusive video interview, Steve Sanghera – CEO and co-founder of Inventus – sat down with pharmaphorum to discuss the company's journey & ethos

Digital

Changing Faces: Digital and supplier hires, June and July 20...

The pharma-adjacent tech and services sectors continued to attract experienced leadership talent during June and July.

Market Access

What India can learn from Kinvard Bio

India needs its own version of pull, designed for an Indian payer mix, an Indian procurement structure, and an Indian distributor network.

Market Access

The new commercialisation playbook: What BIO 2026 taught eme...

BIO International focused on how emerging biotech companies should approach their first product launch outside the United States, typically in Europe.